NBIX · Healthcare · Drug Manufacturers - Specialty & Generic
Neurocrine’s 28% quarter reaches the range top with only 1.1x volume
NBIX closed within 0.6% of its 52-week high after a 6.5% week, but participation was only modest and the Sharemaestro read remains balanced rather than decisive.
168.5 USDLatest Close
6.5%1W Return
6.5%4W Return
28.1%12W Return